SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
03-Jan-23 5:03 PM View: ![]() | Wolin Jonathan S. Chief of Staff, CCO & GC | Jaguar Health, Inc. (JAGX) | 31-Dec-22 | Private Purchase | 317 | $0.03 | $9.51 | 5% 6.67K to 6.98K | |
18-May-22 4:33 PM View: ![]() | Divis Greg J Director | Jaguar Health, Inc. (JAGX) | 18-May-22 | Option Exercise | 12,133 | -- | -- | 100% 0 to 12.13K | |
18-May-22 4:32 PM View: ![]() | Micek John Director | Jaguar Health, Inc. (JAGX) | 18-May-22 | Option Exercise | 12,133 | -- | -- | 100% 0 to 12.13K | |
18-May-22 4:36 PM View: ![]() | Bochnowski James J Director | Jaguar Health, Inc. (JAGX) | 18-May-22 | Option Exercise | 13,133 | -- | -- | 22% 60.63K to 73.77K | |
18-May-22 4:33 PM View: ![]() | Siegel Jonathan B. Director | Jaguar Health, Inc. (JAGX) | 18-May-22 | Option Exercise | 12,133 | -- | -- | 274% 4.42K to 16.56K | |
06-Apr-22 4:32 PM View: ![]() | King Steven R. Chief of Sustainable Supply | Jaguar Health, Inc. (JAGX) | 05-Apr-22 | Option Exercise | 13,333 | -- | -- | 100% 0 to 13.33K | |
06-Apr-22 4:36 PM View: ![]() | Chaturvedi Pravin R Chief Scientific Officer | Jaguar Health, Inc. (JAGX) | 05-Apr-22 | Option Exercise | 3,333 | -- | -- | 100% 0 to 3.33K | |
06-Apr-22 4:34 PM View: ![]() | Wolin Jonathan S. Chief of Staff, CCO & GC | Jaguar Health, Inc. (JAGX) | 05-Apr-22 | Option Exercise | 6,666 | -- | -- | 100% 0 to 6.67K | |
06-Apr-22 4:31 PM View: ![]() | Conte Lisa A CEO and President Director | Jaguar Health, Inc. (JAGX) | 05-Apr-22 | Option Exercise | 45,000 | -- | -- | 562% 8.0K to 53.0K | |
06-Apr-22 4:35 PM View: ![]() | Lizak Carol R. Chief Financial Officer | Jaguar Health, Inc. (JAGX) | 05-Apr-22 | Option Exercise | 4,513 | -- | -- | 57% 7.97K to 12.48K | |
30-Mar-22 9:26 PM View: ![]() | Conte Lisa A CEO and President Director | Jaguar Health, Inc. (JAGX) | 13-Sep-21 | Market Purchase | 7,968 | $2.51 | $19,999.70 | 22766% 35 to 8.0K | (67%) |
30-Mar-22 9:32 PM View: ![]() | Lizak Carol R. Chief Financial Officer | Jaguar Health, Inc. (JAGX) | 13-Sep-21 | Market Purchase Duplicate | 7,968 | $2.51 | $19,999.70 | 100% 0 to 7.97K | (67%) |
07-Jun-21 4:38 PM View: ![]() | Bochnowski James J Director | Jaguar Health, Inc. (JAGX) | 04-Jun-21 | Market Sale | 152 | $1.74 | $264.48 | (< 1%) 954.54K to 954.39K | (2%) |
07-Jun-21 4:38 PM View: ![]() | Bochnowski James J Director | Jaguar Health, Inc. (JAGX) | 03-Jun-21 | Market Sale | 292 | $1.75 | $511.00 | (< 1%) 954.83K to 954.54K | (3%) |
25-Jul-19 4:09 PM View: ![]() | Siegel Jonathan B. Director | Jaguar Health, Inc. (JAGX) | 23-Jul-19 | Market Purchase | 12,705 | $2.00 | $25,410.00 | 2225% 0.57K to 13.28K | |
25-Jul-19 4:08 PM View: ![]() | Bochnowski James J Director | Jaguar Health, Inc. (JAGX) | 23-Jul-19 | Market Purchase | 180,582 | $2.00 | $361,164.00 | 17431% 1.04K to 181.62K | |
05-Oct-18 4:39 PM View: ![]() | Siegel Jonathan B. Director | Jaguar Health, Inc. (JAGX) | 04-Oct-18 | Market Purchase | 25,000 | $0.60 | $15,000.00 | 167% 15.0K to 40.0K | (62%) |
24-Oct-18 9:43 AM View: ![]() | Nantucket Investments Ltd 10% Owner | Jaguar Health, Inc. (JAGX) | 25-Sep-18 | Market Sale | 325,615 | $1.83 | $595,875.00 | (100%) 325.62K to 0 | 88% |
25-Sep-18 9:40 PM View: ![]() | Glaser Jonathan M | Jaguar Health, Inc. (JAGX) | 25-Sep-18 | Gift | 60,000 | -- | -- | (7%) 912.45K to 852.45K | |
20-Jul-18 5:00 PM View: ![]() | Siegel Jonathan B. Director | Jaguar Health, Inc. (JAGX) | 18-Jul-18 | Market Purchase | 5,000 | $1.10 | $5,476.00 | 51% 9.73K to 14.73K | (79%) |
18-Jul-18 5:00 PM View: ![]() | Conte Lisa A CEO and President Director | Jaguar Health, Inc. (JAGX) | 18-Jul-18 | Market Purchase | 1,500 | $1.11 | $1,668.60 | 25% 6.0K to 7.5K | (80%) |
18-Jul-18 5:00 PM View: ![]() | Siegel Jonathan B. Director | Jaguar Health, Inc. (JAGX) | 17-Jul-18 | Market Purchase | 2,232 | $1.19 | $2,656.08 | 30% 7.5K to 9.73K | (81%) |
18-Jul-18 5:00 PM View: ![]() | Siegel Jonathan B. Director | Jaguar Health, Inc. (JAGX) | 16-Jul-18 | Market Purchase | 7,500 | $1.36 | $10,189.50 | 336% 2.23K to 9.73K | (83%) |
02-Aug-17 6:01 AM View: ![]() | Bochnowski James J Director | Jaguar Health, Inc. (JAGX) | 28-Jun-17 | Private Purchase | 100,000 | $0.50 | $50,000.00 | 14% 697.93K to 797.93K | |
09-Feb-16 12:42 PM View: ![]() | Bochnowski James J Director | Jaguar Health, Inc. (JAGX) | 08-Feb-16 | Purchase | 160,000 | $2.50 | $400,000.00 | 49% 327.58K to 487.58K | |
18-May-15 6:07 PM View: ![]() | Bochnowski James J Director | Jaguar Health, Inc. (JAGX) | 18-May-15 | Conversion | 228,688 | $1.97 | $449,994.00 | 231% 98.89K to 327.58K | |
18-May-15 6:03 PM View: ![]() | Bvcf Management, Ltd. 10% Owner | Jaguar Health, Inc. (JAGX) | 18-May-15 | Conversion | 1,483,330 | -- | -- | 3750% 39.55K to 1.52M | |
18-May-15 5:58 PM View: ![]() | Yang Zhi Director 10% Owner | Jaguar Health, Inc. (JAGX) | 18-May-15 | Conversion Duplicate | 1,483,330 | -- | -- | 3750% 39.55K to 1.52M |